Moreover, fisetin exerted anti-inflammatory effects through the suppression of the NF-κB and ERK1/2 signaling pathways in IL-1β-stimulated A549 cells, suggesting to prevent tumor promotion [123]. Here, NFKB1 is linked to neoplasm.